Table 1.
Sample Information Among the 8 Paired Groups Investigated in the Study
Group | Samples | GEO number | Comparison | Sample number |
---|---|---|---|---|
A | Fetal lung | GSE43767 | Mid-term fetal lung versus early-term fetal lung | 9 versus 10 |
B | Fetal lung | GSE43767 | Mature lung versus mid-term fetal lung | 15 versus 9 |
C | AECs | GSE67061 | AECs with lung cancer versus AECs without cancer | 56 versus 17 |
D | AECs | GSE4115 | AECs with lung cancer versus AECs without cancer | 97 versus 90 |
E | AECs | GSE19027 | AECs with lung cancer versus AECs without cancer | 21 versus 39 |
F | Y-BE | GSE67061 | Y-BE p115 versus p25 | 4 versus 4 |
G | LSCC | GSE67061 | Late stage versus early stage* | 22 versus 46 |
H | LSCC | GSE67061 | With lymph node metastasis versus without lymph node metastasis | 33 versus 36 |
Late stage represents Stage III, whereas early stage represents Stages I and II.
AECs, airway epithelial cells; LSCC, lung squamous cell carcinoma.